IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study
Authors
Keywords
Anti-phospholipase A2 receptor, IgG4 subclass, Idiopathic membranous nephropathy, Complement, Clinical outcomes, Meta-analysis
Journal
IMMUNOLOGIC RESEARCH
Volume 64, Issue 4, Pages 919-930
Publisher
Springer Nature
Online
2016-02-02
DOI
10.1007/s12026-016-8790-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of Anti-PLA2R1 as Measured by a Novel ELISA in Patients With Idiopathic Membranous Nephropathy
- (2014) Sjoerd A. M. E. G. Timmermans et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis
- (2014) Shou-Liang Hu et al. JOURNAL OF NEPHROLOGY
- Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy
- (2014) E. Hoxha et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis
- (2014) Yu Du et al. PLoS One
- Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy
- (2013) Cornelia Dähnrich et al. CLINICA CHIMICA ACTA
- Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy
- (2013) Durga Kanigicherla et al. KIDNEY INTERNATIONAL
- IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression
- (2013) Cheng Cheng Huang et al. MODERN PATHOLOGY
- The Role of Complement in Membranous Nephropathy
- (2013) Hong Ma et al. SEMINARS IN NEPHROLOGY
- The continual presence of C3d but not IgG glomerular capillary deposition in stage I idiopathic membranous nephropathy in patients receiving corticosteroid treatment
- (2012) Rui Zhang et al. Diagnostic Pathology
- Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy
- (2012) J. M. Hofstra et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study
- (2012) Maria V. Irazabal et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
- (2011) L. H. Beck et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Idiopathic Membranous Nephropathy: An Autoimmune Disease
- (2011) Sudesh P. Makker et al. SEMINARS IN NEPHROLOGY
- Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy
- (2010) N. Polanco et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- IgG subclasses and complement pathway in segmental and global membranous nephropathy
- (2010) Yoshie Segawa et al. PEDIATRIC NEPHROLOGY
- Current status and issues of C1q nephropathy
- (2009) Akiko Mii et al. Clinical and Experimental Nephrology
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy
- (2009) Laurence H. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Immunoglobulin-Immunoglobulin Interaction in Autoimmunity
- (2008) Shigeyuki Kawa et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More